Disease Areas Insights for Drug Discovery & Translational Research

Select Language

Overview

Disease Areas represent key therapeutic fields driving biologics innovation, where complex biology demands highly relevant, high-quality research tools for target validation, mechanism study, and drug candidate screening. These areas include Autoimmune Diseases, Oncology, Neurodegenerative Diseases, and Metabolic Disorders & Obesity, covering the most critical challenges in global healthcare. At ACROBiosystems, we provide a comprehensive portfolio of recombinant proteins, antibodies, functional cell lines, and assay kits tailored to each disease area, enabling efficient drug discovery and translational research from early target exploration to preclinical and clinical development.

Featured Articles

"Detoxify and Preserve": A New Therapeutic Concept to Tackle TDP-43-Driven Pathogenesis in ALS

Hot

Aug 20, 2026

Hot "Detoxify and Preserve": A New Therapeutic Concept to Tackle TDP-43-Driven Pathogenesis in ALS

ALS remains a major challenge in neurodegenerative disease research, with TDP-43 pathology playing a key role. A recent Nature Aging study introduces a new therapeutic concept: selectively suppressing TDP-43 toxicity while preserving its physiological function.

Autoimmune Disease 3.0: Biomarkers Driving the Future of Precision Drug Development

Hot

Aug 6, 2026

Hot Autoimmune Disease 3.0: Biomarkers Driving the Future of Precision Drug Development

Discover how autoimmune disease biomarkers enable precision drug development by supporting target engagement analysis, pharmacodynamic monitoring, patient stratification, and next-generation immunotherapy programs.

The Brain's Fountain of Youth: How Modern Neuroscience Is Decoding Healthy Brain Aging

Hot

Jul 31, 2026

Hot The Brain's Fountain of Youth: How Modern Neuroscience Is Decoding Healthy Brain Aging

This article explores how modern neuroscience is decoding healthy brain aging, highlighting the research tools accelerating discoveries in brain longevity and Alzheimer’s disease.

Explore by Subtopics

Sigvotatug Vedotin: A Breakthrough in Integrin αvβ6 ADC Therapy for Solid Tumors

Hot

Feb 13, 2025|Disease Areas

Sigvotatug Vedotin: A Breakthrough in Integrin αvβ6 ADC Therapy for Solid Tumors

Potential “Best-in-Class”TL1A Therapy Shows Promising IBD Relief

Hot

Mar 11, 2025|Disease Areas

Potential “Best‑in‑Class”TL1A Therapy Shows Promising IBD Relief

World Inflammatory Bowel Disease Day | ACRO Stands with You in Safeguarding Intestinal Health

Hot

May 15, 2025|Disease Areas

World Inflammatory Bowel Disease Day | ACRO Stands with You in Safeguarding Intestinal Health

Aug 20, 2026|Disease Areas

"Detoxify and Preserve": A New Therapeutic Concept to Tackle TDP‑43‑Driven Pathogenesis in ALS

Aug 6, 2026|Disease Areas

Autoimmune Disease 3.0: Biomarkers Driving the Future of Precision Drug Development

Jul 31, 2026|Disease Areas

The Brain's Fountain of Youth: How Modern Neuroscience Is Decoding Healthy Brain Aging

Jul 24, 2026|Disease Areas

Biomarkers: Enabling Precision Assessment of Cardio‑Kidney‑Metabolic (CKM) Syndrome

Jul 13, 2026|Disease Areas

Beyond Aβ Deposition: What Drives Progression to Dementia?

Resources

Solutions for Autoimmune Disease Drug Development

Request PDF

Aneuro-Advance Neuroscience Research-202303-EN

Request PDF

Solutions for Diabetes-Related and Weight-Management Metabolic Disease Drug Development

Request PDF

Solutions for Autoimmune Disease Drug Development

Request PDF

Aneuro-Advance Neuroscience Research-202303-EN

Request PDF

Solutions for Diabetes-Related and Weight-Management Metabolic Disease Drug Development

Request PDF

Webinars

1/2

Frequently Asked Questions

Why are biomarkers important in translational research?

Biomarkers are important in translational research because they provide measurable indicators of biological processes, disease status, or treatment response. They can support patient stratification, target engagement analysis, response monitoring, and safety assessment. In targeted therapy development, biomarkers may also help identify patient populations most likely to benefit from a specific treatment. By linking laboratory findings with clinical outcomes, biomarkers help improve the efficiency and success of translational development.

How are therapeutic targets identified in disease research?

Therapeutic targets are identified by evaluating a molecule’s role in disease mechanisms and its potential for therapeutic intervention. Researchers often assess genetic evidence, abnormal protein expression, pathway relevance, disease specificity, and differences between diseased and healthy tissues. A strong target should have clear biological relevance and a favorable safety window. Functional validation in relevant preclinical models is then needed to confirm that modulating the target can produce the desired biological effect.

How does disease biology guide drug discovery?

Disease biology provides the foundation for modern drug discovery by helping researchers understand the mechanisms, pathways, and cellular interactions that drive disease. This understanding supports the identification of therapeutic targets, disease-relevant biomarkers, and appropriate experimental models. It also helps researchers connect biological mechanisms with therapeutic strategies more effectively. Relevant disease models, including advanced in vitro systems such as organoids, can further support drug screening, target validation, and translational research.